RHEUMATOLOGY
When a rheumatologist comes to Viper evaluating partnership with a PE-backed MSO or health system, our team brings expertise in biologic infusion therapy optimization, diagnostic testing revenue, patient volume economics, and transaction structures that achieve premium valuations while preserving clinical autonomy in patient care.
Rheumatology practices with strong biologic infusion services, diagnostic capabilities, and established patient bases represent stable, recurring revenue opportunities attractive to PE platforms and health systems. Multi-specialty integration and strong payor relationships significantly impact valuations. Viper guides rheumatology physicians through transactions that maximize infusion service revenue recognition, optimize diagnostic service integration, and structure deals that provide growth capital and operational support while maintaining clinical independence.
THE VIPER APPROACH
Viper Partners is America's leading growth transition consultation firm in the medical industry. Our experienced team of M&A practitioners leverage our exclusive relationships with private equity-funded medical service organizations (MSOs) and family offices to provide the best service and bring you the best deals as you look to sell your dermatology practice.
The Viper Team consults with every single practice-owning dermatologist with high integrity, efficiency, and a one-of-a-kind, value-creation approach, implementing our Viper Value System every step of the way. Our 97% closing rate speaks for itself.
THE VIPER VALUE SYSTEM
High Valuations with Velocity to Victory at the Closing Table
Contact Viper Equity Partners
Call us now at 305-988-5945 or fill out the form below to get in touch.